SkinBioTherapeutics is a life science company focused on skin health. The Companys proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine ONeill and Professor Andrew McBain at The University of Manchester.
| Interim CEO: |
Rachel Parsonage |
| Interim Chairman: |
Alyson Margaret Levett |
| Address: |
Unit 75, Windmill Works, Warfield Road, Kelleythorpe Industrial Estate, Driffield, East Yorkshire, United Kingdom |
| Phone: |
+44 191 495 7325 |
| Fax: |
|
| Website: |
http://www.skinbiotherapeutics.com/ |
| Email: |
|